BioPorto A/S

Copenhagen Stock Exchange BIOPOR.CO

BioPorto A/S Market Capitalization on January 14, 2025: USD 87.80 M

BioPorto A/S Market Capitalization is USD 87.80 M on January 14, 2025, a -25.60% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

BioPorto A/S 52-week high Market Capitalization is USD 147.07 M on July 31, 2024, which is 67.50% above the current Market Capitalization.
BioPorto A/S 52-week low Market Capitalization is USD 65.98 M on April 22, 2024, which is -24.85% below the current Market Capitalization.
BioPorto A/S average Market Capitalization for the last 52 weeks is USD 101.78 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Copenhagen Stock Exchange: BIOPOR.CO

BioPorto A/S

CEO	Mr. Peter Moerch Eriksen B.B.A., BBA
IPO Date	Jan. 13, 2000
Location	Denmark
Headquarters	Tuborg Havnevej 15, st.
Employees	27
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was incorporated in 1917 and is based in Hellerup, Denmark.

Key trends

Past 5 years